- Home
- STRO vs MVBF Comparison
STRO vs MVBF Comparison
Compare STRO & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STRO | MVBF |
|---|---|---|
| Founded | 2003 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.0M | 329.1M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | STRO | MVBF |
|---|---|---|
| Price | $12.22 | $25.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $18.29 | ★ $27.60 |
| AVG Volume (30 Days) | ★ 101.4K | 64.1K |
| Earning Date | 11-06-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 2.62% |
| EPS Growth | N/A | ★ 73.99 |
| EPS | N/A | ★ 2.45 |
| Revenue | $105,646,000.00 | ★ $167,853,000.00 |
| Revenue This Year | $63.08 | N/A |
| Revenue Next Year | N/A | $15.22 |
| P/E Ratio | ★ N/A | $10.62 |
| Revenue Growth | N/A | ★ 18.75 |
| 52 Week Low | $5.23 | $15.59 |
| 52 Week High | $21.50 | $28.96 |
Technical Indicators
Market Signals| Indicator | STRO | MVBF |
|---|---|---|
| Relative Strength Index (RSI) | 76.49 | 42.88 |
| Support Level | $10.15 | $25.29 |
| Resistance Level | $12.18 | $26.32 |
| Average True Range (ATR) | 0.93 | 0.82 |
| MACD | -0.17 | -0.16 |
| Stochastic Oscillator | 94.00 | 16.35 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.